THE API POWDER DIARIES

“The existing scenario has uncovered some structural weaknesses during the EU’s medicines source chain and also a substantial dependence on non-EU nations around the world for active pharmaceutical ingredients,” Kyriakides claimed. She advisable that offer chain concerns be dealt with within an EU pharmaceutical strategy anticipated to be lau